Macrophage polarization alters the expression and sulfation pattern of glycosaminoglycans

Glycobiology

Volumn 25, Issue 5, 2015, Pages 502-513

  Martinez, Pierre ^a   Denys, Agnès ^a   Delos, Maxime ^a   Sikora, Anne Sophie ^a   Carpentier, Mathieu ^a   Julien, Sylvain ^a   Pestel, Joël ^a   Allain, Fabrice ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

Glycosaminoglycan; Macrophage; Sulfotransferases

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; DISACCHARIDE; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCAN; HEPARAN; SULFOTRANSFERASE; GLUCOSAMINOGLYCANS; ISOENZYME;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CARCINOMA CELL LINE; CELL POLARITY; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HISTIOCYTE; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE FUNCTION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASTICITY; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REAL TIME POLYMERASE CHAIN REACTION; SULFATION; UPREGULATION; WESTERN BLOTTING; CELL CULTURE; ENZYMOLOGY; GENETICS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM;

CELLS, CULTURED; GLYCOSAMINOGLYCANS; HUMANS; ISOENZYMES; MACROPHAGE ACTIVATION; MACROPHAGES; SULFOTRANSFERASES;

EID: 84942239574     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu137     Document Type: Article

References (70)

1. Biswas SK, Mantovani A. 2012. Orchestration of metabolism by macrophages. Cell Metab. 15: 432-437.
2. Celie JWAM, Beelen RHJ, van den Born J. 2009. Heparan sulfate proteoglycans in extravasation: assisting leukocyte guidance. Front Biosci (Landmark Ed). 14: 4932-4949.
3. Cesaretti M. 2003. A 96-well assay for uronic acid carbazole reaction. Carbohydr Polym. 54: 59-61.
4. Clasper S, Vekemans S, Fiore M, Plebanski M, Wordsworth P, David G, Jackson DG. 1999. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J Biol Chem. 274: 24113-24123.
5. Deakin JA, Lyon M. 2008. A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sulfates from biological samples. Glycobiology. 18: 483-491.
6. Delehedde M, Deudon E, Boilly B, Hondermarck H. 1996. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells. Exp Cell Res. 229: 398-406.
7. Deligny A, Denys A, Marcant A, Melchior A, Mazurier J, van Kuppevelt TH, Allain F. 2010. Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases. J Biol Chem. 285: 1701-1715.
8. Dennissen MABA, Jenniskens GJ, Pieffers M, Versteeg EMM, Petitou M, Veerkamp JH, van Kuppevelt TH 2002. Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J Biol Chem. 277: 10982-10986.
9. Esko JD, Selleck SB. 2002. Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem. 71: 435-471.
10. Gordon S, Martinez FO. 2010. Alternative activation of macrophages: Mechanism and functions. Immunity. 32: 593-604.
11. Gotte M, Spillmann D, Yip GW, Versteeg E, Echtermeyer FG, van Kuppevelt TH, Kiesel L. 2007. Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (ss4GalT-7) deficient form of Ehlers-Danlos syndrome. Hum Mol Genet. 17: 996-1009.
12. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC. 1993. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem. 268: 23906-23914.
13. Hashimoto-Uoshima M, Noguchi K, Suzuki M, Murata A, Yanagishita M, Ishikawa I. 2002. Effects of interleukin-4 on proteoglycan accumulation in human gingival fibroblasts. J Periodontal Res. 37: 42-49.
14. Jones M, Tussey L, Athanasou N, Jackson DG. 2000. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. J Biol Chem. 275: 7964-7974.
15. Kreuger J, Kjellén L. 2012. Heparan sulfate biosynthesis: regulation and variability. J Histochem Cytochem. 60: 898-907.
16. Van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH. 1998. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem. 273: 12960-12966.
17. Liu C-Y, Xu J-Y, Shi X-Y, Huang W, Ruan T-Y, Xie P, Ding J-L. 2013. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Invest. 93: 844-854.
18. Martinez FO, Gordon S, Locati M, Mantovani A. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 177: 7303-7311.
19. Mikami T, Kitagawa H. 2013. Biosynthesis and function of chondroitin sulfate. Biochim Biophys Acta. 1830: 4719-4733.
20. Mortier A, Van Damme J, Proost P. 2012. Overview of the mechanisms regulating chemokine activity and availability. Immunol Lett. 145: 2-9.
21. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 8: 958-969.
22. Nedvetzki S, Golan I, Assayag N, Gonen E, Caspi D, Gladnikoff M, Yayon A, Naor D. 2003. A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor. J Clin Invest. 111: 1211-1220.
23. Pfaffl MW 2001. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 29: e45.
24. Ruffell B, Poon GFT, Lee SSM, Brown KL, Tjew S-L, Cooper J, Johnson P. 2011. Differential use of chondroitin sulfate to regulate hyaluronan binding by receptor CD44 in Inflammatory and Interleukin 4-activated Macrophages. J Biol Chem. 286: 19179-19190.
25. Sarrazin S, Lamanna WC, Esko JD. 2011. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol. 3: a004952.
26. Smetsers TFCM, van de Westerlo EMA, ten Dam GB, Overes IM, Schalkwijk J, van Muijen GNP, van Kuppevelt TH. 2004. Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J Invest Dermatol. 122: 707-716.
27. Smits NC, Lensen JFM, Wijnhoven TJM, Ten Dam GB, Jenniskens GJ, van Kuppevelt TH 2006. Phage display-derived human antibodies against specific glycosaminoglycan epitopes. Methods Enzymol. 416: 61-87.
28. Taylor KR, Gallo RL. 2006. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20: 9-22.
29. Ten Dam GB, Kurup S, van de Westerlo EMA, Versteeg EMM, Lindahl U, Spillmann D, van Kuppevelt TH. 2006. 3-O-Sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J Biol Chem. 281: 4654-4662.
30. Thacker BE, Xu D, Lawrence R, Esko JD. 2014. Heparan sulfate 3-O-sulfation: A rare modification in search of a function. Matrix Biol J. 35: 60-72.
31. Trottein F, Schaffer L, Ivanov S, Paget C, Vendeville C, Cazet A, Groux-Degroote S, Lee S, Krzewinski-Recchi M-A, Faveeuw C, et al. 2009. Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages. Glycoconj J. 26: 1259-1274.
32. Vijaya Kumar A, Salem Gassar E, Spillmann D, Stock C, Sen Y-P, Zhang T, van Kuppevelt TH, Hülsewig C, Koszlowski EO, Pavao MSG, et al. 2014. HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression. Int J Cancer. 135: 2579-2592.
33. Wegrowski Y, Milard A-L, Kotlarz G, Toulmonde E, Maquart F-X, Bernard J. 2006. Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages. Clin Exp Immunol. 144: 485-493.
34. Wegrowski Y, Paltot V, Gillery P, Kalis B, Randoux A, Maquart FX. 1995. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4. Biochem J. 307(Pt 3):673-678.
35. Zhang L. 2010. Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins. Prog Mol Biol Transl Sci. 93: 1-17.
36. Biswas SK, Mantovani A. 2012. Orchestration of metabolism by macrophages. Cell Metab. 15: 432-437.
37. Celie JWAM, Beelen RHJ, van den Born J. 2009. Heparan sulfate proteoglycans in extravasation: assisting leukocyte guidance. Front Biosci (Landmark Ed). 14: 4932-4949.
38. Cesaretti M. 2003. A 96-well assay for uronic acid carbazole reaction. Carbohydr Polym. 54: 59-61.
39. Clasper S, Vekemans S, Fiore M, Plebanski M, Wordsworth P, David G, Jackson DG. 1999. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J Biol Chem. 274: 24113-24123.
40. Deakin JA, Lyon M. 2008. A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sulfates from biological samples. Glycobiology. 18: 483-491.
41. Delehedde M, Deudon E, Boilly B, Hondermarck H. 1996. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells. Exp Cell Res. 229: 398-406.
42. Deligny A, Denys A, Marcant A, Melchior A, Mazurier J, van Kuppevelt TH, Allain F. 2010. Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases. J Biol Chem. 285: 1701-1715.
43. Dennissen MABA, Jenniskens GJ, Pieffers M, Versteeg EMM, Petitou M, Veerkamp JH, van Kuppevelt TH 2002. Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J Biol Chem. 277: 10982-10986.
44. Esko JD, Selleck SB. 2002. Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem. 71: 435-471.
45. Gordon S, Martinez FO. 2010. Alternative activation of macrophages: Mechanism and functions. Immunity. 32: 593-604.
46. Gotte M, Spillmann D, Yip GW, Versteeg E, Echtermeyer FG, van Kuppevelt TH, Kiesel L. 2007. Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (ss4GalT-7) deficient form of Ehlers-Danlos syndrome. Hum Mol Genet. 17: 996-1009.
47. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC. 1993. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem. 268: 23906-23914.
48. Hashimoto-Uoshima M, Noguchi K, Suzuki M, Murata A, Yanagishita M, Ishikawa I. 2002. Effects of interleukin-4 on proteoglycan accumulation in human gingival fibroblasts. J Periodontal Res. 37: 42-49.
49. Jones M, Tussey L, Athanasou N, Jackson DG. 2000. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. J Biol Chem. 275: 7964-7974.
50. Kreuger J, Kjellén L. 2012. Heparan sulfate biosynthesis: regulation and variability. J Histochem Cytochem. 60: 898-907.
51. Van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH. 1998. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem. 273: 12960-12966.
52. Liu C-Y, Xu J-Y, Shi X-Y, Huang W, Ruan T-Y, Xie P, Ding J-L. 2013. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Lab Invest. 93: 844-854.
53. Martinez FO, Gordon S, Locati M, Mantovani A. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 177: 7303-7311.
54. Mikami T, Kitagawa H. 2013. Biosynthesis and function of chondroitin sulfate. Biochim Biophys Acta. 1830: 4719-4733.
55. Mortier A, Van Damme J, Proost P. 2012. Overview of the mechanisms regulating chemokine activity and availability. Immunol Lett. 145: 2-9.
56. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 8: 958-969.
57. Nedvetzki S, Golan I, Assayag N, Gonen E, Caspi D, Gladnikoff M, Yayon A, Naor D. 2003. A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor. J Clin Invest. 111: 1211-1220.
58. Pfaffl MW 2001. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 29: e45.
59. Ruffell B, Poon GFT, Lee SSM, Brown KL, Tjew S-L, Cooper J, Johnson P. 2011. Differential use of chondroitin sulfate to regulate hyaluronan binding by receptor CD44 in Inflammatory and Interleukin 4-activated Macrophages. J Biol Chem. 286: 19179-19190.
60. Sarrazin S, Lamanna WC, Esko JD. 2011. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol. 3: a004952.
61. Smetsers TFCM, van de Westerlo EMA, ten Dam GB, Overes IM, Schalkwijk J, van Muijen GNP, van Kuppevelt TH. 2004. Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J Invest Dermatol. 122: 707-716.
62. Smits NC, Lensen JFM, Wijnhoven TJM, Ten Dam GB, Jenniskens GJ, van Kuppevelt TH 2006. Phage display-derived human antibodies against specific glycosaminoglycan epitopes. Methods Enzymol. 416: 61-87.
63. Taylor KR, Gallo RL. 2006. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20: 9-22.
64. Ten Dam GB, Kurup S, van de Westerlo EMA, Versteeg EMM, Lindahl U, Spillmann D, van Kuppevelt TH. 2006. 3-O-Sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J Biol Chem. 281: 4654-4662.
65. Thacker BE, Xu D, Lawrence R, Esko JD. 2014. Heparan sulfate 3-O-sulfation: A rare modification in search of a function. Matrix Biol J. 35: 60-72.
66. Trottein F, Schaffer L, Ivanov S, Paget C, Vendeville C, Cazet A, Groux-Degroote S, Lee S, Krzewinski-Recchi M-A, Faveeuw C, et al. 2009. Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages. Glycoconj J. 26: 1259-1274.
67. Vijaya Kumar A, Salem Gassar E, Spillmann D, Stock C, Sen Y-P, Zhang T, van Kuppevelt TH, Hülsewig C, Koszlowski EO, Pavao MSG, et al. 2014. HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression. Int J Cancer. 135: 2579-2592.
68. Wegrowski Y, Milard A-L, Kotlarz G, Toulmonde E, Maquart F-X, Bernard J. 2006. Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages. Clin Exp Immunol. 144: 485-493.
69. Wegrowski Y, Paltot V, Gillery P, Kalis B, Randoux A, Maquart FX. 1995. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4. Biochem J. 307(Pt 3):673-678.
70. Zhang L. 2010. Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins. Prog Mol Biol Transl Sci. 93: 1-17.